Wei B Wu, 4817445 Curry Branch Rd, Louisville, KY 40245
Wei Wu Phones & Addresses
Louisville, KY
Lexington, KY
Alexandria, VA
Tucker, GA
Atlanta, GA
1919 Marietta Dr, Lexington, KY 40505 859-4941085
Work
Position:
Machine Operators, Assemblers, and Inspectors Occupations
Education
Degree:
Graduate or professional degree
Mentions for Wei B Wu
Publications & IP owners
Us Patents
Cd80 And Cd86 Binding Protein Compositions And Uses Thereof
US Patent:
2022025, Aug 18, 2022
Filed:
Feb 22, 2022
Appl. No.:
17/677795
Inventors:
- Rockville MD, US
- Washington DC, US
Martin DEVENPORT - Gaithersburg MD, US
Wei WU - Washington DC, US
Xuexiang DU - Washington DC, US
Mingyue LIU - Washington DC, US
Fei TANG - Washington DC, US
- Washington DC, US
Martin DEVENPORT - Gaithersburg MD, US
Wei WU - Washington DC, US
Xuexiang DU - Washington DC, US
Mingyue LIU - Washington DC, US
Fei TANG - Washington DC, US
Assignee:
ONCOC4, INC. - Rockville MD
CHILDREN'S NATIONAL MEDICAL CENTER - Washington DC
CHILDREN'S NATIONAL MEDICAL CENTER - Washington DC
International Classification:
C07K 14/705
A61P 37/06
A61P 35/00
C07K 16/28
A61K 39/395
C07K 14/00
A61P 37/06
A61P 35/00
C07K 16/28
A61K 39/395
C07K 14/00
Abstract:
This invention relates to CTLA-4 protein compositions and their use in the mitigation of autoimmune adverse events associated with cancer immunotherapy.
Cd80 And Cd86 Binding Protein Compositions And Uses Thereof
US Patent:
2022025, Aug 18, 2022
Filed:
Feb 22, 2022
Appl. No.:
17/677814
Inventors:
- Rockville MD, US
- Washington DC, US
Martin DEVENPORT - Gaithersburg MD, US
Wei WU - Washington DC, US
Xuexiang DU - Washington DC, US
Mingyue LIU - Washington DC, US
Fei TANG - Washington DC, US
- Washington DC, US
Martin DEVENPORT - Gaithersburg MD, US
Wei WU - Washington DC, US
Xuexiang DU - Washington DC, US
Mingyue LIU - Washington DC, US
Fei TANG - Washington DC, US
Assignee:
ONCOC4, INC. - Rockville MD
CHILDREN'S NATIONAL MEDICAL CENTER - Washington DC
CHILDREN'S NATIONAL MEDICAL CENTER - Washington DC
International Classification:
C07K 14/705
A61P 37/06
A61P 35/00
C07K 16/28
A61K 39/395
C07K 14/00
A61P 37/06
A61P 35/00
C07K 16/28
A61K 39/395
C07K 14/00
Abstract:
This invention relates to CTLA-4 protein compositions and their use in the mitigation of autoimmune adverse events associated with cancer immunotherapy.
Methods Of Use Of Soluble Cd24 For Therapy Of Rheumatoid Arthritis
US Patent:
2020039, Dec 24, 2020
Filed:
Sep 1, 2020
Appl. No.:
17/009540
Inventors:
- Rockville MD, US
Wei Wu - Washington DC, US
Yang Liu - Baltimore MD, US
Pan Zheng - Baltimore MD, US
Wei Wu - Washington DC, US
Yang Liu - Baltimore MD, US
Pan Zheng - Baltimore MD, US
Assignee:
OncoImmune, Inc. - Rockville MD
International Classification:
C07K 14/705
C07K 14/435
C07K 19/00
C07K 14/47
C07K 14/435
C07K 19/00
C07K 14/47
Abstract:
Provided herein is a CD24 protein. The CD24 protein may include mature human or mouse CD24, as well as a N- or C-terminally fused portion of a mammalian immunoglobulin.
Cd80 And Cd86 Binding Protein Compositions And Uses Thereof
US Patent:
2019026, Aug 29, 2019
Filed:
Sep 19, 2017
Appl. No.:
16/333888
Inventors:
- Rockville MD, US
- Washington DC, US
Martin DEVENPORT - Gaithersburg MD, US
Wei WU - Washington DC, US
Xuexiang DU - Washington DC, US
Mingyue LIU - Washington DC, US
Fei TANG - Washington DC, US
- Washington DC, US
Martin DEVENPORT - Gaithersburg MD, US
Wei WU - Washington DC, US
Xuexiang DU - Washington DC, US
Mingyue LIU - Washington DC, US
Fei TANG - Washington DC, US
Assignee:
ONCOIMMUNE, INC. - Rockville MD
CHILDREN'S RESEARCH INSTITUTE, CHILDREN'S NATIONAL MEDICAL CENTER - Washington DC
CHILDREN'S RESEARCH INSTITUTE, CHILDREN'S NATIONAL MEDICAL CENTER - Washington DC
International Classification:
C07K 14/705
C07K 16/28
A61P 35/00
A61P 37/06
C07K 16/28
A61P 35/00
A61P 37/06
Abstract:
This invention relates to cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) protein compositions and their use in the mitigation of autoimmune adverse events associated with cancer immunotherapy. Specifically, the disclosure provides a CTLA-4 protein comprising a mutant extracellular domain of CTLA-4, wherein the CTLA-4 protein exhibits reduced binding to an anti-CTLA-4 antibody as compared to a wild-type extracellular domain of CTLA-4, wherein the anti-CTLA-4 antibody has anti-cancer immunotherapeutic activity.
Methods Of Use Of Soluble Cd24 For Therapy Of Rheumatoid Arthritis
US Patent:
2019001, Jan 17, 2019
Filed:
Aug 16, 2018
Appl. No.:
16/104072
Inventors:
- ROCKVILLE MD, US
Wei Wu - Washington DC, US
Yang Liu - Washington DC, US
Pan Zheng - Washington DC, US
Wei Wu - Washington DC, US
Yang Liu - Washington DC, US
Pan Zheng - Washington DC, US
Assignee:
ONCOLMMUNE, INC. - ROCKVILLE MD
International Classification:
C07K 14/705
C07K 14/47
C07K 14/435
C07K 19/00
C07K 14/47
C07K 14/435
C07K 19/00
Abstract:
Provided herein is a CD24 protein. The CD24 protein may include mature human or mouse CD24, as well as a N- or C-terminally fused portion of a mammalian immunoglobulin.
Methods Of Use Of Soluble Cd24 For Therapy Of Rheumatoid Arthritis
US Patent:
2017023, Aug 17, 2017
Filed:
Feb 21, 2017
Appl. No.:
15/437968
Inventors:
- Rockville MD, US
Wei Wu - Washington DC, US
Yang Liu - Washington DC, US
Pan Zheng - Washington DC, US
Wei Wu - Washington DC, US
Yang Liu - Washington DC, US
Pan Zheng - Washington DC, US
International Classification:
C07K 14/705
Abstract:
Provided herein is a CD24 protein. The CD24 protein may include mature human or mouse CD24, as well as a N- or C-terminally fused portion of a mammalian immunoglobulin.
Isbn (Books And Publications)
Generalized Difference Methods For Differential Equations: Numerical Analysis Of Finite Volume Methods
Author:
Wei Wu
ISBN #:
0824703308
Modern Trends In Geomechanics
Author:
Wei Wu
ISBN #:
3540251359
Possible Relatives
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.